A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys. Read this story
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys. Read this story
More from STAT | Pharmaceuticals Pfizer Duchenne muscular dystrophy Gene therapy